Trials / Terminated
TerminatedNCT00069849
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of 2 mg, 4 mg, and 20 mg of ABT-089 BID to placebo in adults with Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-089 |
Timeline
- Start date
- 2003-07-01
- First posted
- 2003-10-02
- Last updated
- 2006-09-04
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00069849. Inclusion in this directory is not an endorsement.